$31.30
0.943.1%
Last update: Nov 10, 4:03 PM
Lycia Therapeutics rose 1.2% from $30.00 to $30.36, ahead of the S&P 500's −1.3%. Its worst day was Oct 27 (−9.5%), and its low came Oct 28 at $25.05.
Story events cover the past 12 months · Times ET
Oct 23, 2026 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Lycia Therapeutics closed at its lowest level of the year, 16.5% below where the year started.
−4.1% · S&P 500 +0.3%
Where it ended: a close of $30.36 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 23, 2026.
Nothing in the past 12 months.
All LYCA earningsNothing in the past 12 months.
All LYCA analyst actionsNothing in the past 12 months.
All LYCA dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LYCA and SPY from Benzinga historical bars. Not investment advice.
